Spondylometaphyseal dysplasia with combined immunodeficiency (Q57461): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed label, description and/or aliases in pt-br, en |
||
| description / pt-br | description / pt-br | ||
Displasia espondilometafisária com imunodeficiência combinada é caracterizada por imunodeficiência combinada, autoimunidade (que se manifesta como vitiligo, doença de Crohn, artrite, tireoidite e trombocitopenia) e displasia espondilometafisária. | |||
| description / en | description / en | ||
Spondylometaphyseal dysplasia with combined immunodeficiency is characterised by combined immunodeficiency, autoimmunity (that manifests as vitiligo, Crohn's disease, arthritis, thyroiditis, and thrombocytopenia), and spondylometaphyseal dysplasia. | |||
Revision as of 05:06, 14 August 2026
Spondylometaphyseal dysplasia with combined immunodeficiency is characterised by combined immunodeficiency, autoimmunity (that manifests as vitiligo, Crohn's disease, arthritis, thyroiditis, and thrombocytopenia), and spondylometaphyseal dysplasia.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | ID_687261501 |
||
| English | Spondylometaphyseal dysplasia with combined immunodeficiency |
Spondylometaphyseal dysplasia with combined immunodeficiency is characterised by combined immunodeficiency, autoimmunity (that manifests as vitiligo, Crohn's disease, arthritis, thyroiditis, and thrombocytopenia), and spondylometaphyseal dysplasia. |
